A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues.
Also Known As:
Brachytherapy, Radioisotope; Interstitial Radiotherapy; Intracavity Radiotherapy; Radioisotope Plaque Therapy; Radiotherapy, Implant; Surface Radiotherapy; Therapy, Radioisotope Plaque; Curietherapy; Implant Radiotherapy; Plaque Therapy, Radioisotope; Radioisotope Brachytherapy; Radiotherapy, Interstitial; Radiotherapy, Intracavity; Radiotherapy, Surface
Networked: 7394 relevant articles (556 outcomes, 1072 trials/studies)

Relationship Network

Therapy Context: Research Results


1. Merrick, Gregory S: 88 articles (09/2015 - 01/2002)
2. Butler, Wayne M: 84 articles (09/2015 - 01/2002)
3. Wallner, Kent E: 75 articles (09/2015 - 10/2002)
4. Pötter, Richard: 74 articles (12/2015 - 04/2002)
5. Galbreath, Robert W: 69 articles (09/2015 - 01/2002)
6. Stock, Richard G: 56 articles (09/2014 - 01/2002)
7. Stone, Nelson N: 54 articles (09/2014 - 01/2002)
8. Kirisits, Christian: 53 articles (12/2015 - 01/2005)
9. Yoshioka, Yasuo: 48 articles (07/2015 - 03/2002)
10. D'Amico, Anthony V: 47 articles (11/2015 - 11/2002)

Related Diseases

1. Neoplasms (Cancer)
12/10/2014 - "Cervical cancer is the third most common cancer in women worldwide; definitive radiation therapy and concurrent chemotherapy is the accepted standard of care for patients with node positive or locally advanced tumors > 4 cm. Brachytherapy is an important part of definitive radiotherapy shown to improve overall survival. "
04/01/2006 - "Brachytherapy is potentially useful in the treatment of head-and-neck cancers, because most tumor sites, such as the lip, tongue, floor of mouth, tonsil, pharynx, nasopharynx, sinuses, and neck, are accessible for the placement of afterloading applicators and catheters. "
10/01/2003 - "The TLCP data indicated that most tumors that contained aerobic cells would be cured, whereas most tumors that contained hypoxic cells would not be cured by total doses of 76 to 80 Gy. Clinical response data from the literature for external beam dose escalation, stratified by PSA value, and for low-dose-rate brachytherapy, were well predicted by the model, where the alpha/beta ratio was 8.5 and 15.5 for well-oxygenated and hypoxic clonogens, respectively. "
11/01/1997 - "Most patients with small size tumor were treated with brachytherapy alone, and the survival rates of these patients were not improved by combination with external irradiation. "
01/01/1991 - "Low dose rate interstitial brachytherapy is extremely useful for those tumors that are accessible for an implant, while the introduction of remote afterloaders has eliminated exposure to nursing personnel. "
2. Prostatic Neoplasms (Prostate Cancer)
3. Carcinoma (Carcinomatosis)
4. Neoplasm Metastasis (Metastasis)
5. Deglutition Disorders (Dysphagia)

Related Drugs and Biologics

1. Iodine
2. sildenafil (Viagra)
3. Cisplatin (Platino)
4. Hormones
5. Protons (Proton)
6. Fluorouracil (Carac)
7. Radioisotopes (Radionuclides)
8. Prostate-Specific Antigen (Semenogelase)
9. Paclitaxel (Taxol)
10. 1-phenyl-3,3-dimethyltriazene (PDT)

Related Therapies and Procedures

1. Radiotherapy
2. Drug Therapy (Chemotherapy)
3. Stents
4. Catheters
5. Prostatectomy (Retropubic Prostatectomy)